期刊
HISTOPATHOLOGY
卷 66, 期 2, 页码 270-282出版社
WILEY
DOI: 10.1111/his.12534
关键词
clinical outcome; colorectal cancer; epigenetic regulation; histone deacetylases; histone modifications
资金
- Leiden University research budget
AimsEpigenetic changes are of crucial importance in cancer development and are potentially reversible; they are therefore targets of interest for anti-cancer therapy. The aim of this study was to investigate the clinical prognostic value of the histone deacetylases SIRT1, HDAC1 and HDAC2 and the histone modifications H4K16Ac and H3K56Ac in colorectal cancer. Methods and resultsThe epigenetic markers were immunohistochemically stained on tissue microarrays containing colorectal tumours (n=254) and normal colorectal tissues (n=50). Nuclear expression was assessed on the semi-automated Ariol system. Multivariate trend survival analyses of the combined markers showed better patient survival and less tumour recurrence when more markers showed high nuclear expression. For the combination of the histone deacetylases and H3K56Ac, the hazard ratio (HR) for overall survival (OS) was 0.82 [95% confidence interval (CI) 0.72-0.94; P=0.005] and the HR for distant recurrence-free survival (DRFS) was 0.77 (95% CI 0.64-0.92; P=0.003) per additional marker showing high expression. Similarly, for the combination of histone deactylases and H4K16Ac, HRs of 0.86 (95% CI 0.76-0.97; P=0.01) for OS and 0.79 (95% CI 0.68-0.93; P=0.006) for DRFS were observed per additional marker showing high expression. ConclusionsThe studied epigenetic markers showed clinical prognostic value in colorectal cancer, both as individual markers and when combined into multimarker analyses. These results indicate that epigenetic mechanisms play an important role in colorectal carcinogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据